DK0470144T3 - D-Asparaginsyre-beta-hydroxamat til behandling af virale infektioner og tumorer - Google Patents

D-Asparaginsyre-beta-hydroxamat til behandling af virale infektioner og tumorer

Info

Publication number
DK0470144T3
DK0470144T3 DK90907159.9T DK90907159T DK0470144T3 DK 0470144 T3 DK0470144 T3 DK 0470144T3 DK 90907159 T DK90907159 T DK 90907159T DK 0470144 T3 DK0470144 T3 DK 0470144T3
Authority
DK
Denmark
Prior art keywords
hydroxamate
aspartic acid
tumors
treatment
viral infections
Prior art date
Application number
DK90907159.9T
Other languages
English (en)
Inventor
Jorge Vila
Nicole Thomasset
Sangsari Farid Hamedi
Jacques Grange
Original Assignee
Inst Nat Sant Et De La Rech M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sant Et De La Rech M filed Critical Inst Nat Sant Et De La Rech M
Application granted granted Critical
Publication of DK0470144T3 publication Critical patent/DK0470144T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90907159.9T 1989-04-28 1990-04-27 D-Asparaginsyre-beta-hydroxamat til behandling af virale infektioner og tumorer DK0470144T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8905744A FR2646348A1 (fr) 1989-04-28 1989-04-28 D-aspartique acide-hydroxamate en tant que medicament

Publications (1)

Publication Number Publication Date
DK0470144T3 true DK0470144T3 (da) 1995-10-02

Family

ID=9381297

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90907159.9T DK0470144T3 (da) 1989-04-28 1990-04-27 D-Asparaginsyre-beta-hydroxamat til behandling af virale infektioner og tumorer

Country Status (11)

Country Link
EP (1) EP0470144B1 (da)
JP (1) JPH04506796A (da)
AT (1) ATE121935T1 (da)
AU (1) AU660916B2 (da)
CA (1) CA2050936A1 (da)
DE (1) DE69019148T2 (da)
DK (1) DK0470144T3 (da)
ES (1) ES2072431T3 (da)
FR (1) FR2646348A1 (da)
OA (1) OA09519A (da)
WO (1) WO1990013291A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705522A (en) * 1995-09-15 1998-01-06 Compagnie De Developpement Aguettant S.A. Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
BR112012006979A2 (pt) * 2009-09-29 2016-04-05 Shiseido Co Ltd composição antioxidante

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600256B1 (fr) * 1986-06-19 1988-09-16 Inst Nat Sante Rech Med Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus

Also Published As

Publication number Publication date
EP0470144A1 (fr) 1992-02-12
OA09519A (fr) 1992-11-15
AU5657590A (en) 1990-11-29
DE69019148D1 (de) 1995-06-08
ATE121935T1 (de) 1995-05-15
AU660916B2 (en) 1995-07-13
CA2050936A1 (fr) 1990-10-29
JPH04506796A (ja) 1992-11-26
ES2072431T3 (es) 1995-07-16
FR2646348A1 (fr) 1990-11-02
DE69019148T2 (de) 1995-08-31
FR2646348B1 (da) 1994-04-22
EP0470144B1 (fr) 1995-05-03
WO1990013291A1 (fr) 1990-11-15

Similar Documents

Publication Publication Date Title
DE3876125D1 (de) Behandlung der menschlichen viralinfektion durch doppelstrang-rna, kombiniert mit viralen inhibitoren.
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
NO963239L (no) Klorpyrimid-mellomprodukter
DK480284A (da) Sporstofmaerkede konjugater af metallothionein og maalsoegende, biologisk aktive molekyler
OA08581A (en) Treatment of diseases caused by retroviruses.
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
ES2051641A1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
EA200300544A1 (ru) Эффективные противоопухолевые лекарственные средства
ES482097A1 (es) Procedimiento para preparar derivados acilicos de carnitina.
DK336688D0 (da) Nucleosider od fremgangsmaade til fremstilling deraf
ATE402713T1 (de) Genetisch manipulierte herpesviren zur behandlung von tumoren
SE9101815D0 (sv) Behandling av sjukdom foerbunden med hiv-infektioner
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
DE58909850D1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
DE3875016D1 (de) Therapeutikum zur behandlung von aids.
DK0470144T3 (da) D-Asparaginsyre-beta-hydroxamat til behandling af virale infektioner og tumorer
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
DE3874606D1 (de) Behandlung von viraler infektion.
DK0817786T3 (da) Substituerede tetronsyrer, der er nyttige til behandling af HIV og andre retrovira
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
DE69619123D1 (de) Hämoregulatorische verbindungen
ATE95062T1 (de) Zusammensetzung zur behandlung von krebs, gekennzeichnet durch ueberexpression des c-fmsproto-onkogens.